Xconomy

JULY 8, 2020

Dave Johnson has known UC San Diego physician and cancer reseacher Thomas Kipps for nearly 20 years.

San Diego 121

San Diego Develop Development UCSD 121

Xconomy

SEPTEMBER 19, 2016

Amid the hue and cry over the Mylan EpiPen pricing debacle , Hillary Clinton unveiled her “ Plan to Respond to Unjustified Price Hikes for Long-Available Drugs. ” Clinton’s plan calls for “dedicated oversight to protect consumers.” That dependence on price increases won’t change any time soon. It has started.”

Pricing 40

Pricing Competition Blogging Journal 40

Xconomy

AUGUST 17, 2018

We also saw a new biotech emerge in the muggy New York heat, a couple deals for new flu vaccines, and interesting developments in the complicated world of drug pricing. Both were landmarks for the companies receiving the nod, Alnylam Pharmaceuticals and Amicus Therapeutics. It’s hot out there. Stay cool with the roundup.

Pricing 52

Pricing Venture Capital Develop Development 52

Xconomy

DECEMBER 18, 2018

The venture investment, which the San Diego startup announced Tuesday, is one of only a few so-called mega-rounds—$100 million or more—recorded this year in the region. (In Thompson to its board of directors. In Southern California, rounds that large are more often raised by life sciences companies.)

Southern California 110

Southern California San Diego Software Invest 110

Xconomy

MAY 10, 2019

The market for drugs for rare or “orphan” diseases continues to grow. An April report from Evaluate Pharma predicted sales of orphan drugs to rise 12 percent a year between now and 2024, when they will account for an estimated 20 percent of worldwide prescription drug sales.

Pricing 97

Pricing Sales Competition Report 97

Xconomy

SEPTEMBER 6, 2019

Being first to market with a new type of drug brings advantages. The first mover sets the bar for what physicians, payers, and patients can expect of that medicine and how much it costs. It grabs market share that followers have to steal away. But the first mover isn’t infallible if someone else has something better. is counting on.

Pricing 84

Pricing Class Study Marketing 84

Xconomy

MARCH 20, 2017

Japan’s Murata Manufacturing has acquired Arctic Sand Technologies of Burlington, MA, and plans to combine Arctic Sand’s low-power semiconductor technology with its San Diego-based subsidiary, Peregrine Semiconductor. The purchase price was $68 million, according to a Peregrine spokeswoman.

San Diego 63

San Diego Mobile Pricing Technology 63

Xconomy

AUGUST 25, 2017

This week saw some skirmishes in the drug price debate, new plans to expand the. Those of us who stepped outside with eclipse glasses, pin-hole projectors, or even colanders found a brief respite from the news. But developments in health policy and life sciences march onward. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Pricing 49

Pricing News Develop Development 49

Xconomy

FEBRUARY 21, 2020

The price of insulin, a life-saving treatment discovered a century ago, has been a flashpoint amid the broader drug pricing debate. The FDA is trying to tame high insulin prices by encouraging price competition. The FDA has historically regarded insulin as a drug.

Pricing 79

Pricing Competition Product Marketing 79

Xconomy

MAY 24, 2019

Patients, doctors, family members, and drug-price watchdogs continued to wait for the expected approval of Zolgensma , a Novartis (NYSE: NVS ) gene therapy for the rare inherited disease spinal muscular atrophy. Originally developed at a children’s hospital in Ohio , Zolgensma will be a litmus test for the nascent field.

Pricing 86

Pricing Marketing Develop Development 86

Xconomy

MAY 9, 2019

billion in new capital late Thursday as it priced an initial public offering that set its market capitalization at $82.4 That price is near the lowest end of the range Uber set at $44 to $50 in the amended prospectus it filed on April 26. Ride-hailing giant Uber secured $8.1

Marketing 88

Marketing Pricing News Capital 88

Xconomy

NOVEMBER 20, 2019

Drug pricing debates and uncertainty associated with Brexit are the issues most likely to keep biopharmaceutical executives awake at night. In turn, pricing pressure is also a concern as corporates and investors plan for the year ahead,”. Nevertheless, senior figures remain optimistic about the industry’s prospects in 2020.

Pricing 78

Pricing Invest Develop Development 78

Xconomy

DECEMBER 14, 2018

Pharmaceutical industry critics lament the cost of rare disease drugs, but some of the steepest price hikes have come on widely used insulin. But the university also allowed them to patent the improvements they made, which enabled them to slap higher prices on each new version. to offer competitive pricing pressure.

Patents 77

Patents Pricing Competition San Diego 77

Xconomy

DECEMBER 13, 2019

If you’re keeping track, FDA drug approvals have been on a tear in the past month with several decisions coming well ahead of their targeted dates. And then there’s Sarepta Therapeutics. Late Thursday, the FDA announced approval of the Cambridge, MA, biotech’s drug for Duchenne muscular dystrophy in patients who have a specific mutation.

Pricing 49

Pricing Southern California USC San Diego 49

Xconomy

MAY 2, 2019

Beyond Meat priced its IPO Wednesday evening at $25 per share, which was the high end of its revised range. million shares at that price. The food technology company’s upsized IPO has raised $241 million to finance plans to bring its plant-based “meat” to more grocery stores and restaurants across the country.

El Segundo 82

El Segundo Pricing Technology Venture Capital 82

Xconomy

AUGUST 16, 2016

The industry can only go so far with growth through hyper-inflated pricing and mega-M&As. At some point pharma has to figure out how to make more drugs more efficiently, or face major dislocations like business-destroying price controls. The increasing need for new drugs is intense.

Product 40

Product Journal Venture Capital Demand 40

Xconomy

JUNE 4, 2018

Inventory management is crucial to operating a successful retail operation. And as hard as it may be to believe, retailers “don’t really know what’s on the shelves,” says Sarjoun Skaff, founder and CTO of Bossa Nova Robotics.

Artificial Inteligence 69

Artificial Inteligence Pricing Product San Diego 69

Xconomy

MARCH 9, 2018

If a shopper interacts with technology in a typical grocery store, it’s usually at the very end—as they are paying for their items. That could be about to change, though.

Pricing 69

Pricing Advertising Ideas Artificial Inteligence 69

Xconomy

JANUARY 20, 2017

Perhaps you’ve heard about the inauguration of one Donald J. Xconomy has been asking prominent members of the national innovation community for their thoughts on the incoming administration and its potential impact on their companies and industries. Here are responses from four business leaders in different cities across Xconomy’s network.

Pricing 40

Pricing Networking Venture Capital San Diego 40

Xconomy

JANUARY 25, 2019

Where the business is based would seem to have an impact on how much money it can raise: If you’re a San Francisco startup, you’d presumably get more money to cover the price of those high-salary engineers and that expensive office. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Startup 101

Startup Pricing Software Capital 101

Xconomy

JULY 19, 2019

Soaring prices of Bitcoin and other so-called digital tokens were attracting investments from speculators hoping to get rich quick—but these virtual coin values were also known to drop just as suddenly, the US Treasury Department’s Financial Stability Oversight Council noted.

Pricing 89

Pricing Report Invest Venture Capital 89

Xconomy

JANUARY 4, 2019

Topics ranged from the worries over CRISPR genome editing and Wild West biohacking, to Nobel Prize-fueled drug approvals and the headaches around drug prices (even for drugs meant to cure headaches). You’ll find a few of our favorite stories in this review of some of the year’s best from across the Xconomy network.

Pricing 69

Pricing Email Networking Silver Lake 69

Xconomy

JULY 25, 2019

On Wednesday evening, Castle priced its offering of 4 million shares at $16 apiece, which was the high end of its targeted price range. Castle Biosciences is joining the public markets through a $64 million IPO that will support cancer tests that help doctors make treatment decisions. million shares in the range of $14 to $16 each.

Training 60

Training Pricing Activity Help 60

Xconomy

MAY 1, 2019

Amazon’s stock price rose by 2.5 percent the day after it announced financial results and changes to the Prime program, while rivals Walmart (NYSE: WMT ) and Target (NYSE: TGT saw their stock prices. The Seattle e-commerce giant told analysts the move would cost around $800 million but that didn’t appear to concern investors.

Commerce 84

Commerce Pricing Startup Demand 84

Xconomy

MAY 17, 2019

During his tenure as FDA commissioner, Scott Gottlieb often spoke about generics as a market force that could help tame climbing drug prices. Generic drugs are supposed to give consumers more choices and a counterweight to more costly branded medications. But such tools only work when companies play fair.

Pricing 79

Pricing Competition Tool Marketing 79

Xconomy

JULY 12, 2016

— 5D Robotics , founded in 2009 in Carlsbad, CA, (about 30 miles north of San Diego), has developed a device that integrates GPS, inertial guidance, optical positioning, and other technologies. SlantRange, a San Diego company founded almost three years ago, is a drone-related startup already generating sales.

San Diego 40

San Diego Seed Funding Guide Technology 40

Xconomy

JANUARY 29, 2019

Previous investors Silverton Partners, Female Founders Fund, and Lakehouse Ventures also participated in Billie’s new round, which the company says will be used for additional product development. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Product 90

Product Services Invest Pricing 90

Xconomy

AUGUST 3, 2018

Millions of people might be on vacation as we hit the dog days, but drug makers and politicians aren’t taking a break from the gamesmanship over high drug prices. Pfizer’s chief executive, recently in Trump’s crosshairs. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Pricing 49

Pricing Venture Capital San Diego Company 49

Xconomy

APRIL 23, 2019

After a breakout year in 2017, the blockchain sector suffered a series of blows in 2018, from crashing cryptocurrency prices to increased regulatory scrutiny of crypto ventures and deepening skepticism about whether the technology was actually useful.

Report 98

Report Pricing Organization Technology 98

Xconomy

JUNE 12, 2019

Sunnyvale, CA-based CrowdStrike (NASDAQ: CRWD ) priced 18 million shares of common stock at $34 on Tuesday. Wednesday, and reached a near-doubling of the company’s IPO price before settling down to close at $58 for a first-day bump of more than 70 percent. That close pegged CrowdStrike’s market capitalization at $11.4

Pricing 54

Pricing Capital Marketing Venture Capital 54

Xconomy

SEPTEMBER 13, 2016

MedCrypt, a healthtech cybersecurity startup founded near San Diego, has raised $750,000 in a seed financing round led by Safeguard Scientifics (NYSE: SFE ), a private equity fund in suburban Philadelphia that invests in healthcare, fintech, and digital media. Jude’s stock price.

San Diego 40

San Diego Startup Software Capital 40

Xconomy

APRIL 5, 2019

Perhaps it’s drug prices. Or maybe it’s regulation. While Gottlieb remained mindful of the FDA’s oversight role, he also tried to streamline the process for reviewing new drugs and medical devices. On numerous occasions, Gottlieb argued that generics would. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Pricing 69

Pricing San Diego Research Blogging 69

Xconomy

MAY 10, 2019

With Uber’s long-awaited IPO, Facebook’s mounting controversies, and ongoing debates over drug pricing and safety issues, come a great responsibility. A big story in the innovation community now is about the ethics and regulation of tech and life sciences.

Pricing 75

Pricing Entrepreneur Venture Capital CalTech 75

Xconomy

NOVEMBER 1, 2018

IBM’s planned $34 billion deal to acquire open-source software maker Red Hat is a hefty price to pay to give its cloud computing business a shot in the arm. In some ways, the biggest software acquisition of all time could be a yawner.

IBM 100

IBM IBM Cloud Computing Google 100

Xconomy

APRIL 6, 2018

There were plenty of policy and drug-price headlines, Read more » Reprints | Share: The FDA didn’t smile upon a big submission of depression studies from Alkermes, while those fighting liver disease got a mixed slate of data as a big medical conference looms.

Study 55

Study Pricing Conference Marketing 55

Xconomy

APRIL 20, 2018

The price of drugs is certainly on a lot of minds these days, including the mind of President Trump, as he reportedly will make a. While pembrolizumab notched the headline-grabbing data, others are also working to develop options for various subsets of patients. Who will be able to afford all these options?

Pricing 52

Pricing News Report Develop 52

Xconomy

SEPTEMBER 1, 2017

billion, the price Gilead Sciences is paying for Kite Pharma and its cancer-fighting cell therapy pipeline. The far-out idea of reprogramming a patient’s immune cells to fight cancer, known as CAR-T, entered the mainstream this week, and two numbers highlight the tale. The first is $11.9

Pricing 74

Pricing Ideas San Diego Study 74